Cargando…

Indeterminate mycobacterium tuberculosis QuantiFERON post Moderna mRNA Covid-19 vaccination

We report an interesting case of an indeterminate MTB QuantiFERON for a 26-year-old healthy soldier planned for a routine field exercise to Brunei. Further medical history revealed that the patient had a Moderna mRNA Covid-19 vaccine the day before his MTB QuantiFERON test. The patient was subsequen...

Descripción completa

Detalles Bibliográficos
Autor principal: Wang, Samuel S.Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tuberculosis Association of India. Published by Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968178/
https://www.ncbi.nlm.nih.gov/pubmed/35760490
http://dx.doi.org/10.1016/j.ijtb.2022.03.019
_version_ 1784678993552736256
author Wang, Samuel S.Y.
author_facet Wang, Samuel S.Y.
author_sort Wang, Samuel S.Y.
collection PubMed
description We report an interesting case of an indeterminate MTB QuantiFERON for a 26-year-old healthy soldier planned for a routine field exercise to Brunei. Further medical history revealed that the patient had a Moderna mRNA Covid-19 vaccine the day before his MTB QuantiFERON test. The patient was subsequently asked to repeat a T-spot test which was non-reactive, there were no longer any issues with the positive control for the T-spot test. Current Covid-19 research suggests that infection causes a dysregulation of the immune system, perhaps this might also be extrapolated where a Covid-19 vaccine might provoke an immune response which might interfere with some immunological assays. In summary there should be more research invested into the immunological interactions that the newly developed Covid-19 vaccinations have with our existing immunological tests such as QuantiFERON tests which forms a key cornerstone in our fight against tuberculosis.
format Online
Article
Text
id pubmed-8968178
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Tuberculosis Association of India. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-89681782022-03-31 Indeterminate mycobacterium tuberculosis QuantiFERON post Moderna mRNA Covid-19 vaccination Wang, Samuel S.Y. Indian J Tuberc Letter to the Editor We report an interesting case of an indeterminate MTB QuantiFERON for a 26-year-old healthy soldier planned for a routine field exercise to Brunei. Further medical history revealed that the patient had a Moderna mRNA Covid-19 vaccine the day before his MTB QuantiFERON test. The patient was subsequently asked to repeat a T-spot test which was non-reactive, there were no longer any issues with the positive control for the T-spot test. Current Covid-19 research suggests that infection causes a dysregulation of the immune system, perhaps this might also be extrapolated where a Covid-19 vaccine might provoke an immune response which might interfere with some immunological assays. In summary there should be more research invested into the immunological interactions that the newly developed Covid-19 vaccinations have with our existing immunological tests such as QuantiFERON tests which forms a key cornerstone in our fight against tuberculosis. Tuberculosis Association of India. Published by Elsevier B.V. 2022-07 2022-03-31 /pmc/articles/PMC8968178/ /pubmed/35760490 http://dx.doi.org/10.1016/j.ijtb.2022.03.019 Text en © 2022 Tuberculosis Association of India. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Wang, Samuel S.Y.
Indeterminate mycobacterium tuberculosis QuantiFERON post Moderna mRNA Covid-19 vaccination
title Indeterminate mycobacterium tuberculosis QuantiFERON post Moderna mRNA Covid-19 vaccination
title_full Indeterminate mycobacterium tuberculosis QuantiFERON post Moderna mRNA Covid-19 vaccination
title_fullStr Indeterminate mycobacterium tuberculosis QuantiFERON post Moderna mRNA Covid-19 vaccination
title_full_unstemmed Indeterminate mycobacterium tuberculosis QuantiFERON post Moderna mRNA Covid-19 vaccination
title_short Indeterminate mycobacterium tuberculosis QuantiFERON post Moderna mRNA Covid-19 vaccination
title_sort indeterminate mycobacterium tuberculosis quantiferon post moderna mrna covid-19 vaccination
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968178/
https://www.ncbi.nlm.nih.gov/pubmed/35760490
http://dx.doi.org/10.1016/j.ijtb.2022.03.019
work_keys_str_mv AT wangsamuelsy indeterminatemycobacteriumtuberculosisquantiferonpostmodernamrnacovid19vaccination